Painchek Ltd (PCK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Painchek Ltd (PCK) has a cash flow conversion efficiency ratio of 2.987x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.28 Million ≈ $-3.03 Million USD) by net assets (AU$-1.43 Million ≈ $-1.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Painchek Ltd (PCK) total market value for the company's overall valuation and market capitalisation.
Painchek Ltd - Cash Flow Conversion Efficiency Trend (2011–2026)
This chart illustrates how Painchek Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Painchek Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Painchek Ltd ranked by their cash flow conversion efficiency. See Painchek Ltd (PCK) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Neuroscientific Biopharmaceuticals Ltd
AU:NSB
|
-0.029x |
|
Donegal Investment Group PLC
IR:DQ7A
|
-0.234x |
|
FACILITIES BY ADF LS-01
F:ZC8
|
N/A |
|
HWH International Inc
NASDAQ:HWH
|
0.171x |
|
Knightscope Inc
NASDAQ:KSCP
|
-0.382x |
|
Millennium Pharmacon International
JK:SDPC
|
-0.062x |
|
Airo Lam limited
NSE:AIROLAM
|
0.083x |
|
Lagnam Spintex Limited
NSE:LAGNAM
|
0.366x |
Annual Cash Flow Conversion Efficiency for Painchek Ltd (2011–2026)
The table below shows the annual cash flow conversion efficiency of Painchek Ltd from 2011 to 2026. View PCK share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | AU$-1.43 Million ≈ $-1.01 Million |
AU$-9.24 Million ≈ $-6.54 Million |
6.449x | +6.28% |
| 2025-06-30 | AU$-1.11 Million ≈ $-787.47K |
AU$-6.75 Million ≈ $-4.78 Million |
6.068x | +209.86% |
| 2024-06-30 | AU$1.29 Million ≈ $913.02K |
AU$-7.13 Million ≈ $-5.04 Million |
-5.524x | +41.63% |
| 2023-06-30 | AU$668.13K ≈ $472.75K |
AU$-6.32 Million ≈ $-4.47 Million |
-9.463x | -552.31% |
| 2022-06-30 | AU$4.82 Million ≈ $3.41 Million |
AU$-7.00 Million ≈ $-4.95 Million |
-1.451x | -190.23% |
| 2021-06-30 | AU$8.24 Million ≈ $5.83 Million |
AU$-4.12 Million ≈ $-2.92 Million |
-0.500x | -9.38% |
| 2020-06-30 | AU$4.13 Million ≈ $2.92 Million |
AU$-1.89 Million ≈ $-1.33 Million |
-0.457x | +38.75% |
| 2019-06-30 | AU$4.12 Million ≈ $2.92 Million |
AU$-3.07 Million ≈ $-2.18 Million |
-0.746x | +17.40% |
| 2018-06-30 | AU$3.22 Million ≈ $2.28 Million |
AU$-2.91 Million ≈ $-2.06 Million |
-0.903x | -42.13% |
| 2017-06-30 | AU$2.48 Million ≈ $1.76 Million |
AU$-1.58 Million ≈ $-1.12 Million |
-0.636x | -123.79% |
| 2016-06-30 | AU$-914.86K ≈ $-647.32K |
AU$-2.44 Million ≈ $-1.73 Million |
2.671x | +19529.85% |
| 2011-06-30 | AU$164.24K ≈ $116.21K |
AU$-2.26K ≈ $-1.60K |
-0.014x | -- |
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more